GT199700123A - Sales dimesilato de los ligandos del neuropeptido y. - Google Patents

Sales dimesilato de los ligandos del neuropeptido y.

Info

Publication number
GT199700123A
GT199700123A GT199700123A GT199700123A GT199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A
Authority
GT
Guatemala
Prior art keywords
compound
neuropeptide
ligands
dimesylate
salts
Prior art date
Application number
GT199700123A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199700123A publication Critical patent/GT199700123A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GT199700123A 1996-11-26 1997-11-25 Sales dimesilato de los ligandos del neuropeptido y. GT199700123A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
GT199700123A true GT199700123A (es) 1999-05-19

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199700123A GT199700123A (es) 1996-11-26 1997-11-25 Sales dimesilato de los ligandos del neuropeptido y.

Country Status (23)

Country Link
US (1) US5914329A (https=)
EP (1) EP0944611B1 (https=)
JP (1) JP3120861B2 (https=)
AP (1) AP9701148A0 (https=)
AR (1) AR010304A1 (https=)
AT (1) ATE257472T1 (https=)
AU (1) AU4792497A (https=)
BR (1) BR9713538A (https=)
CA (1) CA2272927C (https=)
DE (1) DE69727155T2 (https=)
DK (1) DK0944611T3 (https=)
ES (1) ES2213207T3 (https=)
GT (1) GT199700123A (https=)
HN (1) HN1997000154A (https=)
HR (1) HRP970640A2 (https=)
ID (1) ID18964A (https=)
MA (1) MA26450A1 (https=)
PA (1) PA8441701A1 (https=)
PE (1) PE17099A1 (https=)
PT (1) PT944611E (https=)
TN (1) TNSN97191A1 (https=)
WO (1) WO1998023603A1 (https=)
ZA (1) ZA9710587B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
WO2003049673A2 (en) 2001-12-05 2003-06-19 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
ATE321865T1 (de) 2002-01-09 2006-04-15 Arexis Ab Mutationsnachweis
ES2333739T3 (es) * 2004-11-23 2010-02-26 Dong Wha Pharmaceutical Co., Ltd. Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico.
WO2006108218A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014307A1 (en) * 1994-11-07 1996-05-17 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
JP3120861B2 (ja) 2000-12-25
EP0944611A1 (en) 1999-09-29
JP2000505110A (ja) 2000-04-25
MA26450A1 (fr) 2004-12-20
ID18964A (id) 1998-05-28
PT944611E (pt) 2004-04-30
PA8441701A1 (es) 2000-05-24
DE69727155T2 (de) 2004-07-08
US5914329A (en) 1999-06-22
WO1998023603A1 (en) 1998-06-04
PE17099A1 (es) 1999-02-19
EP0944611B1 (en) 2004-01-07
DE69727155D1 (de) 2004-02-12
CA2272927C (en) 2003-02-04
DK0944611T3 (da) 2004-04-13
AU4792497A (en) 1998-06-22
BR9713538A (https=) 2000-03-21
TNSN97191A1 (fr) 2005-03-15
ZA9710587B (en) 1999-05-25
CA2272927A1 (en) 1998-06-04
ES2213207T3 (es) 2004-08-16
AP9701148A0 (en) 1998-01-31
HRP970640A2 (en) 1998-10-31
ATE257472T1 (de) 2004-01-15
AR010304A1 (es) 2000-06-07
HN1997000154A (es) 1999-02-09

Similar Documents

Publication Publication Date Title
ECSP941135A (es) Antagonistas triciclicos de vasopresina de benzacepina
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
HN1997000079A (es) Analogos de indazol sustituido.
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
ES2162198T3 (es) Agentes estrogenos.
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
ES2155844T3 (es) Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos.
EA200000251A1 (ru) Производные резорцинола
ES2178676T3 (es) Compuestos de pirimidina substituidos y su empleo.
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
HN1998000175A (es) Imidazotriazininas
ES2113767T3 (es) Compuestos de tipo ceramidas, su procedimiento de preparacion y su utilizacion en cosmetica o en dermatologia.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
HN1998000166A (es) Compuesto de benceno sustituido procedimiento para su preparacion y composiciones herbicidas y defoliantes que los contienen.
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
BR9811948A (pt) Secretores de hormÈnio do crescimento
BR0316645A (pt) Derivados de isoindol
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
GT199700123A (es) Sales dimesilato de los ligandos del neuropeptido y.
MX9301112A (es) Derivados de indol.
MX9300412A (es) Derivados de 1h-bencimidazol sustituidos con pirroloimidazolilo e imadazopiridinilo
ES2169101T3 (es) Compuesto de metaloceno.
EA200100853A1 (ru) Резорциновая композиция